Transition Therapeutics (NASDAQ: TTHI) commenced an underwritten public offering of its common shares. The Company expects to use net proceeds ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE